Forecasting pharmaceutical expenditure in Europe: adjusting for the impact of rebates and discounts

J. Espin, M. Schlander, B. Godman, P. Anderson, J. Mestre-Ferrandiz, A. Hutchings, S. Flostrand, A. Parnaby

Research output: Contribution to conferenceAbstractpeer-review

33 Downloads (Pure)


European healthcare systems are under constant pressure to contain healthcare expenditure. Understanding future drug expenditure is an important consideration for payers when formulating policies. QuintileIMS publishes European forecasts that are underpinned by its audited volume data and publicly available list prices. With increasing price pressures, list to net price divergence is growing, although some of this information is commercially sensitive and thus not publicly available. The objective of this study was to further develop an established forecast to account for this divergence and explore its impact.
Original languageEnglish
Number of pages1
Publication statusAccepted/In press - 7 Aug 2017
EventISPOR 20th Annual European Congress - Glasgow, United Kingdom
Duration: 4 Nov 20178 Nov 2017
Conference number: 20th


ConferenceISPOR 20th Annual European Congress
CountryUnited Kingdom
Internet address


  • European healthcare
  • healthcare expenditure
  • pharmacoeconomics

Cite this